查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829938

2025年全球组织心臟瓣膜市场报告

Tissue Heart Valves Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，组织心臟瓣膜市场规模稳定成长，从2024年的14.8亿美元增加至2025年的15.2亿美元，复合年增长率为2.3%。预测期内的成长归因于文明病盛行率的上升、医疗支出的增加、老年人口的增长、心臟及病理疾病的增多以及心臟病发病率的上升。

预计未来几年组织心臟瓣膜市场规模将稳定成长，到2029年将达到16.8亿美元，年复合成长率（CAGR）为2.6%。预测期内的增长可归因于心血管疾病盛行率的上升、无缝线手术的日益普及、人口老化、心血管治疗需求的不断增长以及医疗保健投资的不断增加。预测期内的主要趋势包括技术创新、创新培养系统、影像技术的进步、手术技术的进步以及新兴市场的扩张。

组织心臟瓣膜是用于人工心臟瓣膜置换术的生物心臟瓣膜，其设计功能类似天然心臟瓣膜，可取代机械心臟瓣膜。

组织心臟瓣膜主要分为带支架和无支架两种。带支架组织心臟瓣膜是用金属或聚合物框架（支架）加固的生物瓣膜，用于在瓣膜置换术中提供结构支撑并方便植入。这类瓣膜种类繁多，包括主动脉瓣、二尖瓣、三尖瓣和肺动脉瓣。它们被多种终端使用者使用，包括医院、门诊手术中心和其他医疗机构。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供组织心臟瓣膜市场统计数据，例如全球组织心臟瓣膜市场规模、各地区市场份额、竞争对手的市场份额、详细的组织心臟瓣膜细分市场、市场趋势和商业机会，为您提供在组织心臟瓣膜行业取得成功所需的数据。本组织心臟瓣膜市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年2.6%的预测成长率，较我们先前对该市场的预测略有下降0.1%。这一下降主要源自于美国与其他国家之间关税的影响。这可能会直接影响美国，导致来自澳洲和巴西等主要地区的牛心包组织和支架安装零件供应链中断，从而导致心臟瓣膜短缺。此外，由于互惠关税以及贸易紧张局势和限制措施加剧对全球经济和贸易造成的负面影响，这一影响也将波及更广泛的地区。

心血管疾病 (CVD) 的日益普及预计将在未来几年推动组织心臟瓣膜市场的成长。心血管疾病 (CVD) 包括心臟病发作、中风和高血压等疾病，是全球主要死因。这种增长主要是由于不健康的生活方式、人口老化、危险因素的增加、不良饮食、缺乏运动、吸烟、压力和都市化，所有这些都导致​​了心臟相关疾病发病率的上升。组织心臟瓣膜在心血管疾病的置换术中发挥关键作用，它为需要瓣膜置换的患者提供了一种生物相容性、耐用且不易形成血栓的解决方案，最终改善长期心臟功能并减少併发症。例如，根据美国心臟衰竭协会 (HFSA) 2024 年 9 月的报告，大约有 670 万 20 岁及以上的美国人患有心臟衰竭(HF)，预计到 2030 年这一数字将增加到 870 万，到 2040 年将增加到 1030 万，到 2050 万增加到 140 万。心血管疾病负担的增加正在推动对组织心臟瓣膜的需求。

组织心臟瓣膜市场中的公司正专注于技术创新，以改善患者的治疗效果。例如，2024年6月，总部位于爱尔兰的科技公司美敦力公司推出了Avalus Ultra瓣膜，这是一款新一代外科主动脉组织瓣膜领先的有效孔口面积(EOA)，可改善血流。此外，该瓣膜包含一个渗透性线圈，以改善未来瓣中瓣手术中的可视性，并确保主动脉瓣狭窄患者的长期耐用性。

2024年2月，美国医疗设备製造商Foldax Inc.与Dolphin Life Sciences India LLP合作，在印度生产其Tria聚合物二尖瓣外科心臟瓣膜。此次合作将实现印度本土生产和分销，使先进的心臟瓣膜解决方案更容易惠及患者。 Dolphin Life Sciences India LLP是一家专注于心臟瓣膜製造和分销的印度生命科学公司。

组织心臟瓣膜市场包括猪异种移植瓣膜、牛心包瓣膜和自体瓣膜的销售。该市场的价值指的是“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球心臟瓣膜机构市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球组织心臟瓣膜市场：成长率分析
  • 全球组织心臟瓣膜市场表现：规模与成长，2019-2024
  • 全球组织心臟瓣膜市场预测：规模与成长，2024-2029年，2034年
  • 全球组织心臟瓣膜：总目标市场（TAM）

第六章 市场细分

  • 全球组织心臟瓣膜市场：依类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 支架组织心臟瓣膜
  • 无支架组织心臟瓣膜
  • 全球组织心臟瓣膜市场（按瓣膜类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 主动脉
  • 二尖瓣
  • 三尖瓣
  • 肺
  • 全球组织心臟瓣膜市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 门诊手术中心
  • 其他最终用户
  • 全球组织心臟瓣膜市场：支架心臟瓣膜细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 牛
  • 猪肉瓣
  • 全球组织心臟瓣膜市场：无支架组织心臟瓣膜细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 牛无支架瓣膜
  • 同种异体瓣膜

第七章 区域和国家分析

  • 全球组织心臟瓣膜市场：区域表现及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 全球组织心臟瓣膜市场：国家、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 组织心臟瓣膜市场：竞争格局
  • 组织心臟瓣膜市场：公司简介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
    • LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • LifeNet Health Inc.
  • TTK Healthcare Ltd.
  • Braile Biomedica
  • On-X Life Technologies Inc.
  • Anteris Technologies Ltd.
  • Labcor Laboratorios Ltd.
  • CARDION sro
  • CryoLife Inc.
  • Colibri Heart Valve LLC
  • Foldax Inc.
  • Balance Medical Technologies Co. Ltd.
  • MiCardia Corporation
  • Neovasc Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年组织心臟瓣膜市场：提供新机会的国家
  • 2029年组织心臟瓣膜市场：细分领域带来新机会
  • 2029年组织心臟瓣膜市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r34168u

Tissue heart valves are biological heart valves used in replacement surgeries, designed to function such as natural heart valves as an alternative to mechanical ones.

The primary types of tissue heart valves are stented and stentless valves. Stented tissue heart valves are bioprosthetic valves reinforced with a metal or polymer frame (stent) to provide structural support and simplify implantation during valve replacement procedures. These valves come in various types, including aortic, mitral, tricuspid, and pulmonary valves. They are utilized by multiple end-users, such as hospitals, ambulatory surgical centers, and other medical facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The tissue heart valves market research report is one of a series of new reports from The Business Research Company that provides tissue heart valves market statistics, including the tissue heart valves industry global market size, regional shares, competitors with the tissue heart valves market share, detailed tissue heart valves market segments, market trends, and opportunities, and any further data you may need to thrive in the tissue heart valves industry. This tissue heart valves market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tissue heart valves market size has grown steadily in recent years. It will grow from $1.48 billion in 2024 to $1.52 billion in 2025 at a compound annual growth rate (CAGR) of 2.3%. The growth in the historic period can be attributed to the growing prevalence of lifestyle diseases, rising healthcare expenditure, increasing elderly population, increase in cardiac & pathological disorders, and growing incidences of heart diseases.

The tissue heart valves market size is expected to see steady growth in the next few years. It will grow to $1.68 billion in 2029 at a compound annual growth rate (CAGR) of 2.6%. The growth in the forecast period can be attributed to the increasing prevalence of cardiovascular diseases, the rise in popularity of sutureless procedures, the growing aging population, the growing demand for cardiovascular treatments, and increasing healthcare investments. Major trends in the forecast period include technological innovations, innovative culture systems, advancements in imaging technologies, advancements in surgical techniques, and expansion in emerging market.

The forecast of 2.6% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for bovine pericardial tissue and stent mounting components, sourced from key regions such as Australia and Brazil, could lead to shortages in cardiac replacement valves.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of cardiovascular diseases (CVDs) is expected to drive the growth of the tissue heart valves market in the coming years. CVDs, which include conditions such as heart attacks, strokes, and hypertension, are among the leading causes of mortality worldwide. This rise is primarily driven by unhealthy lifestyles, aging populations, increased prevalence of risk factors, poor diets, physical inactivity, smoking, stress, and urbanization, all contributing to higher rates of heart-related disorders. Tissue heart valves play a crucial role in treating cardiovascular diseases by offering a biocompatible, durable, and less thrombogenic solution for patients requiring valve replacement, ultimately improving long-term heart function and reducing complications. For example, in September 2024, a report by the Heart Failure Society of America (HFSA) stated that approximately 6.7 million Americans aged 20 and older are living with heart failure (HF), with projections estimating this number to rise to 8.7 million by 2030, 10.3 million by 2040, and 11.4 million by 2050. This rising burden of CVDs is fueling the demand for tissue heart valves.

Companies operating in the tissue heart valves market are focusing on technological innovations to improve patient outcomes. For instance, in June 2024, Medtronic plc, an Ireland-based technology company, launched the Avalus Ultra valve, a next-generation surgical aortic tissue valve designed to enhance ease of use during implantation and support long-term patient management. This valve, built on a decade of clinical experience with the Avalus valve, features a low profile, a polyetheretherketone (PEEK) base frame for consistent circularity, and an industry-leading Effective Orifice Area (EOA) to improve blood flow. Additionally, it includes a radiopaque coil for better visibility in future valve-in-valve procedures, ensuring long-term durability for patients with aortic stenosis.

In February 2024, Foldax Inc., a US-based medical device company, partnered with Dolphin Life Science India LLP to manufacture the Tria polymer mitral surgical heart valve in India. This collaboration enables in-country production and distribution, making advanced heart valve solutions more accessible to patients. Dolphin Life Science India LLP is an India-based life sciences company specializing in heart valve manufacturing and distribution.

Major players in the tissue heart valves market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, LifeNet Health Inc., TTK Healthcare Ltd., Braile Biomedica, On-X Life Technologies Inc., Anteris Technologies Ltd., Labcor Laboratorios Ltd., CARDION s.r.o., CryoLife Inc., Colibri Heart Valve LLC, Foldax Inc., Balance Medical Technologies Co. Ltd., MiCardia Corporation, Neovasc Inc.

North America was the largest region in the tissue heart valves market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tissue heart valves report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tissue heart valves market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tissue heart valves market consists of sales of porcine xenograft valves, bovine pericardial valves, and autograft valves. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tissue Heart Valves Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tissue heart valves market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tissue heart valves ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tissue heart valves market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Stented Tissue Heart Valves; Stentless Tissue Heart Valves
  • 2) By Valve Type: Aortic; Mitral; Tricuspid; Pulmonary
  • 3) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
  • Subsegments:
  • 1) By Stented Tissue Heart Valves: Bovine Pericardial Valves; Porcine Valves
  • 2) By Stentless Tissue Heart Valves: Bovine Pericardial Stentless Valves; Homograft Valves
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; Edwards Lifesciences Corporation; LivaNova PLC; Meril Life Sciences Pvt. Ltd.; MicroPort Scientific Corporation; LifeNet Health Inc.; TTK Healthcare Ltd.; Braile Biomedica; On-X Life Technologies Inc.; Anteris Technologies Ltd.; Labcor Laboratorios Ltd.; CARDION s.r.o.; CryoLife Inc.; Colibri Heart Valve LLC; Foldax Inc.; Balance Medical Technologies Co. Ltd.; MiCardia Corporation; Neovasc Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tissue Heart Valves Market Characteristics

3. Tissue Heart Valves Market Trends And Strategies

4. Tissue Heart Valves Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Tissue Heart Valves Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tissue Heart Valves PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tissue Heart Valves Market Growth Rate Analysis
  • 5.4. Global Tissue Heart Valves Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tissue Heart Valves Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tissue Heart Valves Total Addressable Market (TAM)

6. Tissue Heart Valves Market Segmentation

  • 6.1. Global Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stented Tissue Heart Valves
  • Stentless Tissue Heart Valves
  • 6.2. Global Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Aortic
  • Mitral
  • Tricuspid
  • Pulmonary
  • 6.3. Global Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End-Users
  • 6.4. Global Tissue Heart Valves Market, Sub-Segmentation Of Stented Tissue Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bovine Pericardial Valves
  • Porcine Valves
  • 6.5. Global Tissue Heart Valves Market, Sub-Segmentation Of Stentless Tissue Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bovine Pericardial Stentless Valves
  • Homograft Valves

7. Tissue Heart Valves Market Regional And Country Analysis

  • 7.1. Global Tissue Heart Valves Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tissue Heart Valves Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tissue Heart Valves Market

  • 8.1. Asia-Pacific Tissue Heart Valves Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tissue Heart Valves Market

  • 9.1. China Tissue Heart Valves Market Overview
  • 9.2. China Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tissue Heart Valves Market

  • 10.1. India Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tissue Heart Valves Market

  • 11.1. Japan Tissue Heart Valves Market Overview
  • 11.2. Japan Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tissue Heart Valves Market

  • 12.1. Australia Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tissue Heart Valves Market

  • 13.1. Indonesia Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tissue Heart Valves Market

  • 14.1. South Korea Tissue Heart Valves Market Overview
  • 14.2. South Korea Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tissue Heart Valves Market

  • 15.1. Western Europe Tissue Heart Valves Market Overview
  • 15.2. Western Europe Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tissue Heart Valves Market

  • 16.1. UK Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tissue Heart Valves Market

  • 17.1. Germany Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tissue Heart Valves Market

  • 18.1. France Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tissue Heart Valves Market

  • 19.1. Italy Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tissue Heart Valves Market

  • 20.1. Spain Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tissue Heart Valves Market

  • 21.1. Eastern Europe Tissue Heart Valves Market Overview
  • 21.2. Eastern Europe Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tissue Heart Valves Market

  • 22.1. Russia Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tissue Heart Valves Market

  • 23.1. North America Tissue Heart Valves Market Overview
  • 23.2. North America Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tissue Heart Valves Market

  • 24.1. USA Tissue Heart Valves Market Overview
  • 24.2. USA Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tissue Heart Valves Market

  • 25.1. Canada Tissue Heart Valves Market Overview
  • 25.2. Canada Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tissue Heart Valves Market

  • 26.1. South America Tissue Heart Valves Market Overview
  • 26.2. South America Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tissue Heart Valves Market

  • 27.1. Brazil Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tissue Heart Valves Market

  • 28.1. Middle East Tissue Heart Valves Market Overview
  • 28.2. Middle East Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tissue Heart Valves Market

  • 29.1. Africa Tissue Heart Valves Market Overview
  • 29.2. Africa Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tissue Heart Valves Market Competitive Landscape And Company Profiles

  • 30.1. Tissue Heart Valves Market Competitive Landscape
  • 30.2. Tissue Heart Valves Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis

31. Tissue Heart Valves Market Other Major And Innovative Companies

  • 31.1. Meril Life Sciences Pvt. Ltd.
  • 31.2. MicroPort Scientific Corporation
  • 31.3. LifeNet Health Inc.
  • 31.4. TTK Healthcare Ltd.
  • 31.5. Braile Biomedica
  • 31.6. On-X Life Technologies Inc.
  • 31.7. Anteris Technologies Ltd.
  • 31.8. Labcor Laboratorios Ltd.
  • 31.9. CARDION s.r.o.
  • 31.10. CryoLife Inc.
  • 31.11. Colibri Heart Valve LLC
  • 31.12. Foldax Inc.
  • 31.13. Balance Medical Technologies Co. Ltd.
  • 31.14. MiCardia Corporation
  • 31.15. Neovasc Inc.

32. Global Tissue Heart Valves Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tissue Heart Valves Market

34. Recent Developments In The Tissue Heart Valves Market

35. Tissue Heart Valves Market High Potential Countries, Segments and Strategies

  • 35.1 Tissue Heart Valves Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tissue Heart Valves Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tissue Heart Valves Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer